Sotera Health Company
Last updated September 27, 2026
Organization details
- Legal name
- Sotera Health Company
- Former names
- Sotera Health Topco, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8090 — Services-Misc Health & Allied Services, NEC
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Broadview Heights
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SHC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001822479
- EIN
- 47-3531161
Board of directors
-
Alton Shader · Director · Chief Executive OfficerSince 2026
-
Ann R. Klee · DirectorSince 2023
-
Christopher Simon · DirectorSince 2024
-
Constantine S. Mihas · DirectorSince 2023
-
David Donnini · DirectorSince 2023
-
David E. Wheadon · DirectorSince 2023
-
James Neary · DirectorSince 2023
-
Karen Flynn · DirectorSince 2023
-
Kenneth D. Krause · DirectorSince 2026
-
Michael B. Petras Jr. · Director · Executive ChairmanSince 2023
-
Richard G. Kyle · DirectorSince 2026
-
Robert Brown Knauss · DirectorSince 2023
-
Ruoxi Chen · DirectorSince 2023
-
Sean Laurence Cunningham · DirectorSince 2023
-
Vincent K. Petrella · DirectorSince 2023
Chief executives
Alton Shader
· Chief Executive Officer
Since May 2026
Michael B. Petras Jr.
· Chairman & CEO
Until May 2026
· Former
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.6%
-
95.3%
-
96.0%
-
98.5%
Board connections
10 of this board's directors also sit on 13 other boards.
- via Constantine S. Mihas and Sean Laurence Cunningham
- via Vincent K. Petrella
- via Christopher Simon
- via David E. Wheadon
- via Karen Flynn
- via David E. Wheadon
- via Richard G. Kyle
- via Karen Flynn
- via Vincent K. Petrella
- via Richard G. Kyle
- via David Donnini
- via James Neary
- via Ann R. Klee
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,594,389,216
- 18 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Michael B. Petras Jr. Director, Officer (Executive Chairman) | Open-market sale | −294,515 | $18.50 | $5,448,851 |
| Aug 17, 2026 | Michael B. Petras Jr. Director, Officer (Executive Chairman) | Open-market sale | −850,000 | $18.50 | $15,725,935 |
| Aug 7, 2026 | Rutz Michael P Officer (President of Sterigenics) | Open-market sale | −150,000 | $18.84 | $2,825,250 |
| Aug 5, 2026 | Lyons Jonathan M. Officer (Sr. Vice President, CFO) | Shares withheld for tax | −11,316 | $17.98 | $203,462 |
| May 26, 2026 | Alton Shader Director, Officer (Chief Executive Officer) | Grant or award | +375,939 | — | — |
| May 26, 2026 | Alton Shader Director, Officer (Chief Executive Officer) | Grant or award | +203,634 | — | — |
| May 22, 2026 | Ann R. Klee Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Richard G. Kyle Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Kenneth D. Krause Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Sean Laurence Cunningham Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Karen Flynn Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | James Neary Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Vincent K. Petrella Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Ruoxi Chen Director | Grant or award | +14,970 | — | — |
| May 22, 2026 | Christopher Simon Director | Grant or award | +14,970 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.